Joint venture Recipharm and Medspray

Recipharm’s investment in Resyca has been made through its subsidiary Recipharm BV. This investment enables exciting opportunities for pharmaceuticals being delivered by soft mist inhalers.

Resyca will operate development facilities in Enschede, The Netherlands and Munich, Germany. Spray nozzles will be supplied exclusively from Medspray in the Netherlands. It is envisaged that commercial supply of finished devices will be manufactured and supplied by other Recipharm affiliates including the specialist device manufacturing capabilities located in King’s Lynn, UK.

Additionally, Recipharm will receive an exclusive license to offer its customers the development and manufacturing of syringe-based devices using the softmist nozzle technology. Such devices will be marketed by Recipharm under the brand Bespak by Recipharm.

The company will be managed by Bernhard Müllinger and Wilbur de Kruijf.